Keynote 1: State of Biotech in Beijing/China
China is the world's fastest growing pharmaceutical market. A senior government official povides insights into how Beijing is influencing the future of the industry in Beijing and throughout China.

Keynote 2: Financial Drivers of China Biotech
China's biotech industry is driven by government and venture capital funding, big pharma interests, and investors' ability to exit. Greg Scott, founder of ChinaBio^®, explores the financial foundation of the industry and how these factors are driving the industry forward at "China speed."

Break and Refreshment

10:15-11:45

Panel 1: Raising Venture Capital
Over $400M US was invested in life science companies in 2007. Hear directly from leading VC investors in China life science what they look for in early and mid-stage companies.

Luncheon

Panel 2: Doing Deals: Collaboration and Licensing
A key step in a biotech company's growth is a collaboration, co-development or licensing deal with a big pharma. Business development executives from big pharma tell how they work with China biotechs to do deals that can change a company's probability of success.

Break and Refreshment

Panel 3: Exiting: M&A and IPO Transactions
The ultimate step in a company's life cycle for the investors and executives is the exit. A panel of deal makers and investment bankers tell what it takes to make the final leap to an acquisition or IPO.

Keynote 3: 2020 – A Look at the Future of China Biotech
The future appears very bright for China's biotech industry with some predicting it will be #1, but many challenges remain. A leading expert explores if/how the hurdles will be overcome and what industry will look 12 years from now.

Shuttle Buses to Banquet

Banquet - Sponsored by BayHelix Group
Chajiafu Restaurant